Briefs	E-mail PagePrint Version

ROCKET SOFTWARE EXPANDS SOUTH AFRICAN PARTNERSHIP
 
ALAMEDA - Rocket Software OSS Unit (formerly TCSI Corp.) has successfully completed acceptance and installation of the latest software release to manage national and international connectivity for Telkom SA Limited, the largest provider of wireless and wireline telephony in southern Africa.

Rocket Software's SS7 NMS adds new configuration management functionality to support a new generation of devices and will improve Telkom's security and graphical interface, as well as support a new version of Telkom's carrier-grade SS7 network signaling solution.
 
The SS7 NMS, or SNMS, manages several key functions, including Fault Management, Configuration Management, Performance and Security Management. The two companies have been working together since 1997, and this contract is the latest enhancement to a successful SS7 domain management system that has been running for more than five years.
 
The Rocket Software OSS Unit was formed in 2003 as a result of the acquisition of TCSI Corporation, a leading provider of software products and services for the global telecommunications industry.
 
The company's OSS software is installed in more than 300 networks around the world, and customers include a "Who's Who" of telecom players including China Telecom, Verizon, Motorola, Lucent, NTT and NEC. The Rocket OSS Unit is based in Alameda, California, with offices in Europe and the Pacific Rim.
 
Telkom SA Limited is one of the largest companies registered in the Republic of South Africa and is the largest communications services provider on the African continent based on operating revenue and assets.

INCYTE TO CLOSE PALO ALTO RESEARCH CENTER

PALO ALTO - Incyte Corporation has said it will close its Palo Alto, California research facilities and headquarters, effective April 2, completing its transition to a drug discovery and development company.
 
As a result, Incyte will reduce its workforce by 257 employees and expects to eliminate approximately $50 million in annual operating expenses.
 
According to a company spokesman, the action "will not affect Incyte's ability to leverage its extensive gene-related intellectual property portfolio or to collect milestone and royalty payments associated with its prior and current LifeSeq subscription agreements…given the infrastructure costs in Palo Alto, combined with the expected decrease in our 2004 revenue, the decision to cease operations in California is essential to complete our transition into a drug discovery and development company."

Incyte will continue to operate its Proteome subsidiary in Beverly, Massachusetts, which produces the BioKnowledge Library (BKL) information product line that provides fundamental biological information about human, animal, and microbial proteins based on expert, literature-based annotation.

Go back, or read the latest briefs:

TRADE

empty